In contrast, a different study involving 81 pancreatic cancer (PCA) cases and 81 matched controls revealed that circulating Ahsg levels were comparable between patients and controls and were not linked to the severity of the disease [51]. The gene discussed is AHSG; the disease is posterior cortical atrophy.